RAPP Buy Disclosure
Maraganore John · SEC Form 4 · Filed Oct 22, 2026
Buy
Calculated transaction value
$217.34K
Maraganore John Director
RAPP
Rapport Therapeutics
RAPP
Transaction date
Oct 22, 2026
Public filing date
Oct 22, 2026
Filing lag
Filed same day
RAPP daily price context
Close on/before transaction
$26.53
Oct 22, 2026
First close after public filing
$25.93
Oct 23, 2026
Return after filing · so far
+0.54%
Through Nov 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 8,239 shares @ $26.38
- SEC ownership
- Indirect
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001193125-26-429071
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$248.89K
Buys / sales
2 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Rapport Therapeutics, Inc. RAPP Current | Buy | Oct 22, 2026 | $217.34K |
| Rapport Therapeutics, Inc. RAPP | Buy | Oct 22, 2026 | $31.55K |